Kangmei Pharma | 600518 - Zahlungsmittel Und Äquivalente

Aktienkurs
1.71
Täglich Wechseln
0 0%
Monatlich
-2.84%
Jährlich
-10.94%
Q2 Prognose
1.69




Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
Avita Medical AUD 10.24M 1.98M 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Genomma Lab Internacional MXN 2.81B 264.13M 2026-03
Hypermarcas BRL 1.65B 218.22M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Jiangsu Hengrui CNY 40.96B 591.41M 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Moderna USD 2.6B 1.46B 2025-12
Organon & Co USD 672M 73M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Sh Fosun Pharma CNY 11.48B 1.48B 2025-09
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Viatris USD 1.32B 347.1M 2025-12
Wuxi Apptec CNY 35.13B 5.69B 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06